Annual Interest Expense
$87.90 M
+$50.60 M+135.66%
31 December 2023
Summary:
Emergent BioSolutions annual interest expense is currently $87.90 million, with the most recent change of +$50.60 million (+135.66%) on 31 December 2023. During the last 3 years, it has risen by +$56.60 million (+180.83%). EBS annual interest expense is now at all-time high.EBS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$8.30 M
-$15.30 M-64.83%
30 September 2024
Summary:
Emergent BioSolutions quarterly interest expense is currently $8.30 million, with the most recent change of -$15.30 million (-64.83%) on 30 September 2024. Over the past year, it has dropped by -$11.40 million (-57.87%). EBS quarterly interest expense is now -70.98% below its all-time high of $28.60 million, reached on 30 June 2023.EBS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$77.90 M
-$11.40 M-12.77%
30 September 2024
Summary:
Emergent BioSolutions TTM interest expense is currently $77.90 million, with the most recent change of -$11.40 million (-12.77%) on 30 September 2024. Over the past year, it has dropped by -$1.10 million (-1.39%). EBS TTM interest expense is now -17.39% below its all-time high of $94.30 million, reached on 31 March 2024.EBS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +135.7% | -57.9% | -1.4% |
| 3 y3 years | +180.8% | -1.2% | +127.8% |
| 5 y5 years | +787.9% | -19.4% | +107.7% |
EBS Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +180.8% | -71.0% | +6.4% | -17.4% | +133.2% |
| 5 y | 5 years | at high | +787.9% | -71.0% | +29.7% | -17.4% | +149.7% |
| alltime | all time | at high | -71.0% | >+9999.0% | -17.4% |
Emergent BioSolutions Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.30 M(-64.8%) | $77.90 M(-12.8%) |
| June 2024 | - | $23.60 M(-2.9%) | $89.30 M(-5.3%) |
| Mar 2024 | - | $24.30 M(+12.0%) | $94.30 M(+7.3%) |
| Dec 2023 | $87.90 M(+135.7%) | $21.70 M(+10.2%) | $87.90 M(+11.3%) |
| Sept 2023 | - | $19.70 M(-31.1%) | $79.00 M(+16.5%) |
| June 2023 | - | $28.60 M(+59.8%) | $67.80 M(+44.3%) |
| Mar 2023 | - | $17.90 M(+39.8%) | $47.00 M(+26.0%) |
| Dec 2022 | $37.30 M(+8.1%) | $12.80 M(+50.6%) | $37.30 M(+11.3%) |
| Sept 2022 | - | $8.50 M(+9.0%) | $33.50 M(+0.3%) |
| June 2022 | - | $7.80 M(-4.9%) | $33.40 M(-2.3%) |
| Mar 2022 | - | $8.20 M(-8.9%) | $34.20 M(-0.9%) |
| Dec 2021 | $34.50 M(+10.2%) | $9.00 M(+7.1%) | $34.50 M(+0.9%) |
| Sept 2021 | - | $8.40 M(-2.3%) | $34.20 M(+2.4%) |
| June 2021 | - | $8.60 M(+1.2%) | $33.40 M(+7.1%) |
| Mar 2021 | - | $8.50 M(-2.3%) | $31.20 M(-0.3%) |
| Dec 2020 | $31.30 M(-18.5%) | $8.70 M(+14.5%) | $31.30 M(-1.3%) |
| Sept 2020 | - | $7.60 M(+18.8%) | $31.70 M(-7.8%) |
| June 2020 | - | $6.40 M(-25.6%) | $34.40 M(-8.3%) |
| Mar 2020 | - | $8.60 M(-5.5%) | $37.50 M(-2.6%) |
| Dec 2019 | $38.40 M(+287.9%) | $9.10 M(-11.7%) | $38.50 M(+2.7%) |
| Sept 2019 | - | $10.30 M(+8.4%) | $37.50 M(+34.9%) |
| June 2019 | - | $9.50 M(-1.0%) | $27.80 M(+44.0%) |
| Mar 2019 | - | $9.60 M(+18.5%) | $19.30 M(+94.9%) |
| Dec 2018 | $9.90 M(+50.0%) | $8.10 M(+1250.0%) | $9.90 M(+271.3%) |
| Sept 2018 | - | $600.00 K(-40.0%) | $2.67 M(-34.3%) |
| June 2018 | - | $1.00 M(+400.0%) | $4.06 M(-16.6%) |
| Mar 2018 | - | $200.00 K(-76.9%) | $4.86 M(-26.3%) |
| Dec 2017 | $6.60 M(-13.2%) | $866.00 K(-56.5%) | $6.60 M(-20.0%) |
| Sept 2017 | - | $1.99 M(+10.3%) | $8.25 M(-0.7%) |
| June 2017 | - | $1.80 M(-6.9%) | $8.31 M(+3.7%) |
| Mar 2017 | - | $1.94 M(-23.0%) | $8.02 M(+5.4%) |
| Dec 2016 | $7.60 M | $2.52 M(+22.9%) | $7.60 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $2.05 M(+35.7%) | $6.68 M(+6.6%) |
| June 2016 | - | $1.51 M(-0.9%) | $6.27 M(-1.8%) |
| Mar 2016 | - | $1.52 M(-4.8%) | $6.39 M(-2.1%) |
| Dec 2015 | $6.52 M(-20.8%) | $1.60 M(-2.1%) | $6.52 M(+7.0%) |
| Sept 2015 | - | $1.64 M(+0.4%) | $6.10 M(-2.8%) |
| June 2015 | - | $1.63 M(-2.0%) | $6.27 M(-1.5%) |
| Mar 2015 | - | $1.66 M(+41.5%) | $6.37 M(-22.7%) |
| Dec 2014 | $8.24 M(>+9900.0%) | $1.17 M(-35.1%) | $8.24 M(+16.6%) |
| Sept 2014 | - | $1.81 M(+5.2%) | $7.07 M(+34.4%) |
| June 2014 | - | $1.72 M(-51.3%) | $5.26 M(+48.6%) |
| Mar 2014 | - | $3.54 M(>+9900.0%) | $3.54 M(>+9900.0%) |
| Sept 2013 | - | $0.00(-100.0%) | $20.00 K(0.0%) |
| June 2013 | - | $3000.00(-72.7%) | $20.00 K(+17.6%) |
| Mar 2013 | - | $11.00 K(+83.3%) | $17.00 K(+88.9%) |
| Dec 2012 | $6000.00(>+9900.0%) | $6000.00(>+9900.0%) | $9000.00(+200.0%) |
| Sept 2012 | - | $0.00(0.0%) | $3000.00(0.0%) |
| June 2012 | - | $0.00(-100.0%) | $3000.00(-66.7%) |
| Mar 2012 | - | $3000.00(>+9900.0%) | $9000.00(+50.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $6000.00(0.0%) |
| Sept 2011 | - | $0.00(-100.0%) | $6000.00(0.0%) |
| June 2011 | - | $6000.00(>+9900.0%) | $6000.00(+200.0%) |
| Mar 2011 | - | $0.00(0.0%) | $2000.00(-71.4%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $7000.00(>+9900.0%) |
| Sept 2010 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2010 | - | $2000.00(-60.0%) | $4000.00(-50.0%) |
| Mar 2010 | - | $5000.00(-171.4%) | $8000.00(+14.3%) |
| Dec 2009 | $7000.00(-85.1%) | -$7000.00(-275.0%) | $7000.00(-50.0%) |
| Sept 2009 | - | $4000.00(-33.3%) | $14.00 K(+40.0%) |
| June 2009 | - | $6000.00(+50.0%) | $10.00 K(+11.1%) |
| Mar 2009 | - | $4000.00(-20.0%) | $9000.00(+50.0%) |
| Dec 2008 | $47.00 K | - | - |
| June 2008 | - | $5000.00(+400.0%) | $6000.00(+500.0%) |
| Mar 2008 | - | $1000.00 | $1000.00 |
FAQ
- What is Emergent BioSolutions annual interest expense?
- What is the all time high annual interest expense for Emergent BioSolutions?
- What is Emergent BioSolutions annual interest expense year-on-year change?
- What is Emergent BioSolutions quarterly interest expense?
- What is the all time high quarterly interest expense for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly interest expense year-on-year change?
- What is Emergent BioSolutions TTM interest expense?
- What is the all time high TTM interest expense for Emergent BioSolutions?
- What is Emergent BioSolutions TTM interest expense year-on-year change?
What is Emergent BioSolutions annual interest expense?
The current annual interest expense of EBS is $87.90 M
What is the all time high annual interest expense for Emergent BioSolutions?
Emergent BioSolutions all-time high annual interest expense is $87.90 M
What is Emergent BioSolutions annual interest expense year-on-year change?
Over the past year, EBS annual interest expense has changed by +$50.60 M (+135.66%)
What is Emergent BioSolutions quarterly interest expense?
The current quarterly interest expense of EBS is $8.30 M
What is the all time high quarterly interest expense for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly interest expense is $28.60 M
What is Emergent BioSolutions quarterly interest expense year-on-year change?
Over the past year, EBS quarterly interest expense has changed by -$11.40 M (-57.87%)
What is Emergent BioSolutions TTM interest expense?
The current TTM interest expense of EBS is $77.90 M
What is the all time high TTM interest expense for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM interest expense is $94.30 M
What is Emergent BioSolutions TTM interest expense year-on-year change?
Over the past year, EBS TTM interest expense has changed by -$1.10 M (-1.39%)